Lisanti Capital Growth, LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2022$8,225,000
-37.2%
169,767
-49.1%
1.10%
-38.1%
Q2 2022$13,094,000
+34.4%
333,272
+25.9%
1.78%
+62.5%
Q1 2022$9,744,000
-2.3%
264,698
+20.9%
1.09%
-24.2%
Q4 2021$9,976,000218,8601.44%
Other shareholders
CYTOKINETICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders